News Dupixent works in hard-to-treat form of atopic dermatitis IL-4 inhibitor shows its worth in atopic hand-foot dermatitis unresponsive to corticosteroids.
News Sanofi cuts price of Lantus insulin in US by 78% Pharma joins Eli Lilly, Novo Nordisk as it slashes the price of its widely-prescribed insulins.
News Sanofi buys Provention and diabetes drug Tzield for $2.9bn T1D prevention drug has been tipped as a blockbuster, boosting Sanofi's diabetes franchise.
News Sanofi sings a song for rare disease and equitable care 'This is Rare' campaign sings the plight of the rare disease community this awareness day.
News Sanofi boosts ‘connected insulin’ push with Glooko deal The alliance will pair Glooko's digital health platform with Sanofi's SoloSmart insulin device.
News Sanofi gets FDA nod for long-acting haemophilia A drug Once-weekly Altuviiio could be potential $2 billion-plus blockbuster, according to analysts.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
